AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ariza, J
Right arrow Articles by Martín, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ariza, J
Right arrow Articles by Martín, R

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1986 December; 30(6): 958-960

Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis.

J Ariza, J Bosch, F Gudiol, J Liñares, P F Viladrich and R Martín

ABSTRACT

The in vitro susceptibility of Brucella melitensis was examined vis-a-vis the clinical outcome in 75 patients with brucellosis. The initial MICs for Brucella isolates from patients who relapsed and from those who did not were similar. Furthermore, the MICs for isolates from patients whose infections relapsed were no different from those for original isolates. Our results clearly showed that neither initial nor subsequent antibiotic susceptibility plays a role in the likelihood of relapse of patients with brucellosis.


Antimicrob Agents Chemother. 1986 December; 30(6): 958-960




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 1986 by the American Society for Microbiology. All rights reserved.